Colorectal Cancer Associated Host and Microbiome Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03998644|
Recruitment Status : Recruiting
First Posted : June 26, 2019
Last Update Posted : July 2, 2019
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||2000 participants|
|Official Title:||A Study Focused on the Host and Microbiome of Colorectal Cancer Patients|
|Actual Study Start Date :||December 2015|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2025|
Subjects without colorectal disorders.
Subjects with risk factors that may contribute to the carcinogenesis.
Patients who were identified by standard procedures to suffer with colorectal cancer.
- Gut microbiota structure and function difference between colorectal cancer, precancer and healthy controls [ Time Frame: average of 5 years ]The results were based on the 16S rRNA metagenomic sequencing.
- Metabolic difference of blood samples between colorectal cancer, precancer and healthy controls [ Time Frame: average of 5 years ]The metabolites of the blood samples by LC-MS will be detected.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03998644
|Contact: Huanlong Qin, Ph.Demail@example.com|
|Shanghai 10th People's Hospital||Recruiting|
|Shanghai, Shanghai, China, 200072|
|Contact: Renyuan Gao, MD firstname.lastname@example.org|
|Principal Investigator: Huanlong Qin, PhD|